A recent Obstetrics & Gynaecology digest,
as sent to subscribers

Study Type: Retrospective cohort study

Key Question: Which antenatal clinical and social factors predict term birth in nulliparous First Nations women, and can these be combined into a usable prediction score?

Key Findings:

• Among 30,509 nulliparous First Nations women, 89% delivered at term; 11% preterm (57% spontaneous, 43% medically indicated).
• Strongest predictors of term birth: singleton pregnancy (OR 24.64), absence of chorioamnionitis (OR 11.22), absence of placental abruption (OR 10.93), and absence of fetal abdominal wall anomalies (OR 11.19).
• Term birth also associated with ≥5 antenatal visits, metropolitan residence, higher socioeconomic status, younger maternal age, spontaneous conception, and absence of substance use.

Clinical Relevance: These findings support development of a culturally tailored, antenatally-derived risk score to identify First Nations women needing enhanced, equity-focused antenatal support—relevant to NHS efforts addressing ethnic disparities in preterm birth outcomes.

Limitations: Retrospective design using routinely collected data limits causal inference and generalisability beyond the Queensland First Nations population; external validation is needed.

Study Type: Case-control experimental (translational biomarker) study

Key Question: Can protein content of peritoneal fluid-derived small extracellular vesicles distinguish women with endometriosis from controls, independent of disease stage or menstrual cycle phase?

Key Findings:

• sEVs were confirmed in peritoneal fluid across 63 samples using NTA, immunoblotting, and mass spectrometry.
• Four proteins differed significantly between groups: ALDOA (3.12-fold higher, controls; p=0.0164), HSP90AA1 (2.14-fold higher, controls; p=0.0245), COL15A1 (1.83-fold higher, controls; p=0.0421), and S100-A10 (2.54-fold higher, endometriosis; p=0.0421).
• Differences were consistent regardless of rASRM stage or cycle phase.

Clinical Relevance: This exploratory work identifies candidate peritoneal biomarkers that could underpin future non-invasive diagnostic tests for endometriosis, addressing a key NHS priority of reducing diagnostic delay currently averaging 8 years.

Limitations: Small sample size without independent validation cohort, and no functional assays to confirm biological relevance of the identified proteins.

Study Type: Narrative literature review

Key Question: How can male reproductive health management in ART clinics be improved across diagnostics, treatment, education, and psychosocial care?

Key Findings:

• Men attending ART clinics rarely receive routine health follow-up; current treatment (e.g. ICSI) bypasses underlying causes of infertility rather than addressing them.
• Paternal factors (age, oxidative stress, DNA damage, epigenetics) are increasingly linked to embryo development and offspring health, yet sperm-focused research lags behind oocyte/embryo optimisation.
• Slow clinical uptake of novel diagnostics/technologies is attributed largely to poor collaboration between researchers and clinicians, alongside absent integration of mental health support.

Clinical Relevance: UK ART services should consider multidisciplinary models incorporating GPs, urologists, endocrinologists, andrologists, and mental health professionals to improve diagnosis, treatment, and psychosocial support for men undergoing fertility treatment, aligning with broader NHS pushes for holistic, patient-centred fertility care.

Limitations: As a narrative (non-systematic) review without a registered protocol, conclusions reflect selective synthesis rather than a rigorously appraised evidence base.

Study Type: Systematic review and meta-analysis (with health economic analysis)

Key Question: Does PGT-A improve live birth rate, safety, or cost-effectiveness in IVF/ICSI compared with IVF/ICSI without PGT-A?

Key Findings:

• Live birth per randomised woman was not increased with PGT-A, either per first embryo transfer (OR 1.16, 95% CI 0.94–1.45) or cumulatively per oocyte retrieval (OR 0.87, 95% CI 0.64–1.19); low certainty evidence, including in women >35 years.
• Live birth per embryo transfer was higher with PGT-A (low certainty), reflecting selection bias from excluding women who never reach transfer; miscarriage rate impact was uncertain (very low certainty), and no trial showed shorter time to live birth.
• No increase in obstetric or child health complications after embryo biopsy (PGT-A/M/SR); in a Swedish cost model, PGT-A nearly doubled IVF cost with no live birth benefit.

Clinical Relevance: Reinforces professional society guidance against routine PGT-A use in NHS/UK fertility services, given lack of proven benefit in the clinically meaningful per-patient outcome and substantial added cost.

Limitations: Only seven RCTs met strict eligibility criteria (all-chromosome PGT-A, per-randomised-woman outcome), and overall certainty of evidence remains low to very low.

Study Type: Randomised, pragmatic, non-blinded clinical trial

Key Question: Does extending the hips (vs usual flexed positioning) at crowning reduce significant perineal lacerations during first vaginal delivery in nulliparous women?

Key Findings:

• ITT analysis (n=1,206): no difference in significant perineal lacerations (66.6% intervention vs 66.2% usual care, P=.89); 25% non-adherence in intervention arm.
• Unadjusted as-treated analysis showed lower rates of significant lacerations (62.7% vs 68.7%, P=.03) and OASI (5.2% vs 9.9%, P=.004) with extension, but these lost significance after adjustment.
• Adjusted ordinal analysis still showed a protective shift toward intact perineum/fewer OASIs with extension (P=.03).

Clinical Relevance: Despite a signal favouring hip extension in secondary/as-treated analyses, this trial does not support changing standard UK intrapartum positioning practice to reduce perineal trauma, as the primary ITT outcome was null.

Limitations: Substantial non-adherence to allocated positioning undermines the validity of the as-treated findings and limits causal inference.

Study Type: Multicentre prospective cohort study (propensity-weighted comparative analysis)

Key Question: Does laparoscopic radiofrequency ablation (RFA) achieve comparable symptom and quality-of-life improvements to myomectomy for symptomatic uterine leiomyomas over 24 months?

Key Findings:

• Both RFA (n=237) and myomectomy (n=164) produced significant, sustained improvements in Symptom Severity Scale (SSS) and HRQOL scores over 2 years.
• Myomectomy showed statistically greater improvement (SSS difference -5.27, P=.028; HRQOL difference -6.62, P=.011), but these fell below minimal clinically important difference thresholds (SSS 10 points; HRQOL 20 points).
• Early functional advantages for myomectomy (activities, control, self-consciousness) at 6 months were not sustained at 24 months.

Clinical Relevance: Supports laparoscopic RFA as a clinically comparable, less invasive uterus-sparing alternative to myomectomy for symptomatic fibroids, relevant to NHS fertility-preserving treatment pathways and resource planning.

Limitations: Non-randomised design with potential residual confounding from treatment selection, despite propensity weighting.